(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Generac Holdlings, BioLineRx Ltd., and BioLife Solutions.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Generac Holdlings (GNRC) | 95.20 | 13.24% | 2023-11-01 12:20:04 |
| 2 | BioLineRx Ltd. (BLRX) | 1.50 | 12.78% | 2023-11-01 07:49:05 |
| 3 | BioLife Solutions (BLFS) | 10.10 | 12.35% | 2023-11-01 07:46:06 |
| 4 | LendingTree (TREE) | 14.83 | 12.09% | 2023-11-01 12:14:52 |
| 5 | Nautilus (NLS) | 0.82 | 11.2% | 2023-11-01 12:57:05 |
| 6 | Aldeyra Therapeutics (ALDX) | 1.71 | 11.04% | 2023-10-31 19:23:05 |
| 7 | Ascent Solar Technologies (ASTI) | 0.91 | 10.57% | 2023-11-01 01:09:05 |
| 8 | Garmin (GRMN) | 112.21 | 9.44% | 2023-11-01 12:12:43 |
| 9 | Ardelyx (ARDX) | 3.95 | 9.12% | 2023-10-31 23:13:05 |
| 10 | AMD (AMD) | 106.65 | 8.28% | 2023-11-01 12:10:39 |
The three biggest losers today are Lumen Technologies, Estee Lauder Companies, and Match Group.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Lumen Technologies (LUMN) | 1.05 | -28.42% | 2023-11-01 13:00:59 |
| 2 | Estee Lauder Companies (EL) | 106.48 | -17.37% | 2023-11-01 12:54:29 |
| 3 | Match Group (MTCH) | 28.97 | -16.27% | 2023-11-01 12:16:34 |
| 4 | Trimble (TRMB) | 39.94 | -15.26% | 2023-11-01 12:14:56 |
| 5 | Unum Group (UNM) | 42.99 | -12.08% | 2023-11-01 12:59:42 |
| 6 | Ebix (EBIX) | 5.40 | -11.33% | 2023-11-01 12:11:56 |
| 7 | V.F. Corporation (VFC) | 13.23 | -10.22% | 2023-11-01 12:22:24 |
| 8 | Canaan (CAN) | 1.78 | -7.55% | 2023-11-01 12:15:51 |
| 9 | Bionano Genomics (BNGO) | 1.29 | -6.88% | 2023-11-01 12:15:46 |
| 10 | E.I. du Pont de Nemours and Company (DD) | 67.95 | -6.76% | 2023-11-01 12:54:09 |
Winners today
1. Generac Holdlings (GNRC) – 13.24%
Generac Holdings Inc. designs, manufactures, and sells power generation equipment, energy storage systems, energy management devices and solutions, and other power products for the residential, light commercial, and industrial markets worldwide. The company offers residential automatic standby generators, automatic transfer switch, air-cooled engine residential standby generators, and liquid-cooled engine generators; residential storage solution consists of a system of batteries, an inverter, photovoltaic optimizers, power electronic controls, and other components; Mobile Link, a remote monitoring system for home standby generators; smart home solutions, such as smart thermostats and a suite of home monitoring products; smart water heater controllers; residential clean energy solutions; and portable and inverter generators; outdoor power equipment, including trimmers, field and brush mowers, log splitters, stump grinders, chipper shredders, lawn and leaf vacuums, and pressure washers and water pumps; and battery-powered turf care products. It also provides commercial and industrial products comprising cleaner-burning natural gas fueled generators; light-commercial standby generators and related transfer switches; stationary generators and related transfer switches; single-engine industrial generators; industrial standby generators; industrial transfer switches; light towers, mobile generators, and mobile energy storage systems; and aftermarket service parts and product accessories. The company distributes its products through independent residential dealers, industrial distributors and dealers, national and regional retailers, e-commerce partners, electrical, HVAC and solar wholesalers, catalogs, equipment rental companies and distributors, and solar installers; and directly to end users. The company was founded in 1959 and is headquartered in Waukesha, Wisconsin.
NYSE ended the session with Generac Holdlings jumping 13.24% to $95.20 on Wednesday, after two successive sessions in a row of gains. NYSE rose 0.56% to $15,002.55, after two consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Generac Holdlings has a trailing twelve months EPS of $2.39.
PE Ratio
Generac Holdlings has a trailing twelve months price to earnings ratio of 39.83. Meaning, the purchaser of the share is investing $39.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.87%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Generac Holdlings’s EBITDA is 86.61.
More news about Generac Holdlings.
2. BioLineRx Ltd. (BLRX) – 12.78%
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in patients with acute respiratory distress syndrome secondary to COVID-19 and other respiratory viral infections, as well as for the treatment of solid tumors and acute myeloid leukemia. It is also developing AGI-134, an immuno-oncology agent, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and BL-5010, a customized, proprietary, pen-like applicator for the non-surgical removal of skin lesions. The company has collaboration agreement with MSD for the cancer immunotherapy field; MD Anderson Cancer Center to investigate the combination of Motixafortide with KEYTRUDA (pembrolizumab) in pancreatic cancer; and licensing arrangement with Perrigo Company plc for over-the-counter sale of BL-5010. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
NASDAQ ended the session with BioLineRx Ltd. jumping 12.78% to $1.50 on Wednesday while NASDAQ rose 1.64% to $13,061.47.
Earnings Per Share
As for profitability, BioLineRx Ltd. has a trailing twelve months EPS of $-0.6.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -111.53%.
More news about BioLineRx Ltd..
3. BioLife Solutions (BLFS) – 12.35%
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
NASDAQ ended the session with BioLife Solutions rising 12.35% to $10.10 on Wednesday while NASDAQ jumped 1.64% to $13,061.47.
Earnings Per Share
As for profitability, BioLife Solutions has a trailing twelve months EPS of $-1.94.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.83%.
Moving Average
BioLife Solutions’s value is way below its 50-day moving average of $12.38 and way below its 200-day moving average of $18.83.
More news about BioLife Solutions.
4. LendingTree (TREE) – 12.09%
LendingTree, Inc., through its subsidiary, LT Intermediate Company, LLC, operates online consumer platform in the United States. It operates through three segments: Home, Consumer, and Insurance. The Home segment offers purchase mortgage, refinance mortgage, reverse mortgage, and home equity loans; lines of credit; and real estate brokerage services. The Consumer segment provides credit cards; personal, small business, student, and auto loans; deposit accounts; and other credit products, such as credit repair and debt settlement services. The Insurance segment includes information, tools, and access to insurance quote products, including home and automobile, through which consumers are matched with insurance lead aggregators to obtain insurance offers. In addition, the company offers QuoteWizard.com, a marketplace for insurance comparison; ValuePenguin, a personal finance website that offers consumers objective analysis on various financial topics from insurance to credit cards; and Stash, a consumer investing and banking platform that offers a suite of personal investment accounts, traditional and Roth IRAs, custodial investment accounts, and banking services, including checking accounts and debit cards with a Stock-Back rewards program. The company was formerly known as Tree.com, Inc. and changed its name to LendingTree, Inc. in January 2015. LendingTree, Inc. was incorporated in 1996 and is based in Charlotte, North Carolina.
NASDAQ ended the session with LendingTree rising 12.09% to $14.83 on Wednesday, after four sequential sessions in a row of gains. NASDAQ jumped 1.64% to $13,061.47, after three successive sessions in a row of gains, on what was an all-around bullish trend exchanging session today.
Earnings Per Share
As for profitability, LendingTree has a trailing twelve months EPS of $-12.19.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -52.6%.
Volatility
LendingTree’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.96%, a negative 1.72%, and a positive 2.45%.
LendingTree’s highest amplitude of average volatility was 1.96% (last week), 3.56% (last month), and 2.45% (last quarter).
More news about LendingTree.
5. Nautilus (NLS) – 11.2%
Nautilus, Inc., a fitness solutions company, designs, develops, sources, and markets cardio and strength fitness products, and related accessories for consumer use in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company operates through two segments, Direct and Retail. It offers cardio products, exercise bikes, treadmills, ellipticals, home gyms, dumbbells, kettlebells, and barbells primarily under the Nautilus, Bowflex, and Schwinn brands, as well as digital fitness platform under the JRNY brand. In addition, it engages in licensing its brands and intellectual properties. The company offers its products directly to consumers through television advertising, social media, websites, and catalogs; and through a network of retail companies consisting of sporting goods stores, online-only retailers, electronics stores, furniture stores, and large-format and warehouse stores, as well as specialty retailers and independent bike dealers. Nautilus, Inc. was founded in 1986 and is headquartered in Vancouver, Washington.
NYSE ended the session with Nautilus jumping 11.2% to $0.82 on Wednesday while NYSE jumped 0.56% to $15,002.55.
Earnings Per Share
As for profitability, Nautilus has a trailing twelve months EPS of $-1.63.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 75.4%.
Yearly Top and Bottom Value
Nautilus’s stock is valued at $0.82 at 17:32 EST, way under its 52-week high of $2.17 and way above its 52-week low of $0.64.
Sales Growth
Nautilus’s sales growth for the current quarter is negative 20.2%.
More news about Nautilus.
6. Aldeyra Therapeutics (ALDX) – 11.04%
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma. The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
NASDAQ ended the session with Aldeyra Therapeutics jumping 11.04% to $1.71 on Wednesday, after two successive sessions in a row of gains. NASDAQ rose 1.64% to $13,061.47, after three consecutive sessions in a row of gains, on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, Aldeyra Therapeutics has a trailing twelve months EPS of $-0.89.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -34.26%.
Moving Average
Aldeyra Therapeutics’s worth is way below its 50-day moving average of $5.54 and way under its 200-day moving average of $7.69.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Aldeyra Therapeutics’s EBITDA is -41.03.
More news about Aldeyra Therapeutics.
7. Ascent Solar Technologies (ASTI) – 10.57%
Ascent Solar Technologies, Inc. designs, manufactures, and sells copper-indium-gallium-diselenide photovoltaic products for aerospace, defense, emergency management, and consumer/OEM applications. It offers outdoor solar chargers. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies. Ascent Solar Technologies, Inc. was incorporated in 2005 and is based in Thornton, Colorado.
NASDAQ ended the session with Ascent Solar Technologies rising 10.57% to $0.91 on Wednesday, following the last session’s upward trend. NASDAQ jumped 1.64% to $13,061.47, after three sequential sessions in a row of gains, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, Ascent Solar Technologies has a trailing twelve months EPS of $-188.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Ascent Solar Technologies’s EBITDA is -4.49.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 2.4%.
Volume
Today’s last reported volume for Ascent Solar Technologies is 331200 which is 68.58% below its average volume of 1054380.
More news about Ascent Solar Technologies.
8. Garmin (GRMN) – 9.44%
Garmin Ltd. designs, develops, manufactures, markets, and distributes a range of wireless devices in the Americas, the Asia Pacific, Australian Continent, Europe, the Middle East, and Africa. Its Fitness segment offers running and multi-sport watches; cycling products; activity tracking and smartwatch devices; fitness and cycling accessories. This segment also provides Garmin Connect and Garmin Connect Mobile, which are web and mobile platforms; and Connect IQ, an application development platform. The company's Outdoor segment offers adventure watches, outdoor handhelds, golf devices and mobile apps, and dog tracking and training devices. Its Aviation segment designs, manufactures, and markets various aircraft avionics solutions comprising integrated flight decks, electronic flight displays and instrumentation, navigation and communication products, automatic flight control systems and safety-enhancing technologies, audio control systems, engine indication systems, traffic awareness and avoidance solutions, ADS-B and transponder solutions, weather information and avoidance solutions, datalink and connectivity solutions, portable GPS navigators and wearables, and various services products. The company's Marine segment provides chartplotters and multi-function displays, cartography products, fishfinders, sonar products, autopilot systems, radars, compliant instrument displays and sensors, VHF communication radios, handhelds and wearable devices, sailing products, entertainment, digital switching products, and trolling motors. Its Auto segment offers embedded domain controllers and infotainment systems; personal navigation devices; and cameras. The company sells its products through independent retailers, dealers, distributors, installation and repair shops, and original equipment manufacturers, as well as an online webshop, garmin.com. Garmin Ltd. was founded in 1989 and is based in Schaffhausen, Switzerland.
NASDAQ ended the session with Garmin jumping 9.44% to $112.21 on Wednesday, after two successive sessions in a row of gains. NASDAQ jumped 1.64% to $13,061.47, after three sequential sessions in a row of gains, on what was an all-around bullish trend exchanging session today.
Garmin (grmn) Q3 earnings: taking a look at key metrics versus estimatesHere is how Garmin performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Earnings Per Share
As for profitability, Garmin has a trailing twelve months EPS of $5.17.
PE Ratio
Garmin has a trailing twelve months price to earnings ratio of 21.7. Meaning, the purchaser of the share is investing $21.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.59%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 4% and 4.4%, respectively.
Sales Growth
Garmin’s sales growth is 5.6% for the ongoing quarter and 5.1% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Garmin’s stock is considered to be oversold (<=20).
More news about Garmin.
9. Ardelyx (ARDX) – 9.12%
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD. The company has agreements with Kyowa Kirin in Japan, Fosun Pharmaceutical Industrial Development Co. Ltd. in China, and Knight Therapeutics, Inc. in Canada for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
NASDAQ ended the session with Ardelyx rising 9.12% to $3.95 on Wednesday, after two successive sessions in a row of gains. NASDAQ rose 1.64% to $13,061.47, after three sequential sessions in a row of gains, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, Ardelyx has a trailing twelve months EPS of $-0.23.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -63.67%.
Volume
Today’s last reported volume for Ardelyx is 14868200 which is 117.66% above its average volume of 6830730.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 21.4% and a drop 200% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 784.1%, now sitting on 82.87M for the twelve trailing months.
Sales Growth
Ardelyx’s sales growth is 480.9% for the present quarter and negative 15% for the next.
Previous days news about Ardelyx
- Ardelyx (ardx) Q3 earnings and revenues top estimates. According to Zacks on Tuesday, 31 October, "While Ardelyx has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
More news about Ardelyx.
10. AMD (AMD) – 8.28%
Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. It operates in four segments: Data Center, Client, Gaming, and Embedded segments. The company offers x86 microprocessors and graphics processing units (GPUs) as an accelerated processing unit, chipsets, data center, and professional GPUs; and embedded processors, and semi-custom system-on-chip (SoC) products, microprocessor and SoC development services and technology, data processing unites, field programmable gate arrays (FPGA), and adaptive SoC products. It also provides processors under the AMD Ryzen, AMD Ryzen PRO, Ryzen Threadripper, Ryzen Threadripper PRO, AMD Athlon, AMD Athlon PRO, and AMD PRO A-Series brand names; graphics under the AMD Radeon graphics and AMD Embedded Radeon graphics; and professional graphics under the AMD Radeon Pro graphics brand name. In addition, the company offers data center graphics under the Radeon Instinct and Radeon PRO V-series brands, as well as servers under the AMD Instinct accelerators brand; server microprocessors under the AMD EPYC brands; embedded processor solutions under the AMD Athlon, AMD Geode, AMD Ryzen, AMD EPYC, AMD R-Series, and G-Series brands; FPGA products under the Virtex-6, Virtex-7, Virtex UltraScale+, Kintex-7, Kintex UltraScale, Kintex UltraScale+, Artix-7, Artix UltraScale+, Spartan-6, and Spartan-7 brands; adaptive SOCs under the Zynq-7000, Zynq UltraScale+ MPSoC, Zynq UltraScale+ RFSoCs, Versal HBM, Versal Premium, Versal Prime, Versal AI Core, Versal AI Edge, Vitis, and Vivado brands; and compute and network acceleration board products under the Alveo brand. It serves original equipment and design manufacturers, public cloud service providers, system integrators, independent distributors, online and brick and mortar retailers, and add-in-board manufacturers through its direct sales force, independent distributors, and sales representatives. The company was incorporated in 1969 and is headquartered in Santa Clara, California.
NASDAQ ended the session with AMD jumping 8.28% to $106.65 on Wednesday while NASDAQ rose 1.64% to $13,061.47.
AMD Q3 earnings beat, top line aided by solid client growthAs of Sep 30, 2023, AMD had cash and cash equivalents (including marketable securities) of $5.79 billion compared with $6.29 billion as of Jul 1, 2023., Sequentially, revenues increased 21%, driven by strong adoption of fourth-generation AMD EPYC CPUs.
Earnings Per Share
As for profitability, AMD has a trailing twelve months EPS of $-0.04.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.05%.
Moving Average
AMD’s worth is above its 50-day moving average of $103.55 and higher than its 200-day moving average of $99.67.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 4.5% and positive 20.3% for the next.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 26, 1995, the estimated forward annual dividend yield is 1.16%.
Volatility
AMD’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.05%, a negative 0.32%, and a positive 2.11%.
AMD’s highest amplitude of average volatility was 1.92% (last week), 1.96% (last month), and 2.11% (last quarter).
Previous days news about AMD
- Despite mixed market trends, AMD receives strong support from analysts ahead of Q3. According to Business Insider on Monday, 30 October, "Mosesmann expects AMD to strike a bullish posture in all strategic product areas, including the new MI300A/X APU/GPU compute accelerators, which he sees as much more competitive than the Street believes.", "Pajjuri flags that MI300X GPU for Gen AI will likely launch in 4Q and believe AMD is working withMicrosoft Corp(NASDAQ:MSFT),Meta Platforms Inc(NASDAQ:META), andAmazon."
More news about AMD.
Losers Today
1. Lumen Technologies (LUMN) – -28.42%
Lumen Technologies, Inc., a facilities-based technology and communications company, provides various integrated products and services under the Lumen, Quantum Fiber, and CenturyLink brands to business and residential customers in the United States and internationally. The company operates in two segments, Business and Mass Markets. It offers compute and application services, such as edge cloud services, IT solutions, unified communication and collaboration solutions, colocation and data center services, content delivery services, and managed security services; and IP and data services, including VPN data network, Ethernet, internet protocol (IP), and voice over internet protocol. The company also provides fiber infrastructure services comprising high bandwidth optical wavelength networks; and unlit optical fiber and related professional services. In addition, it offers voice and other services, including private line services, a direct circuit or channel specifically dedicated for connecting two or more organizational sites; a portfolio of traditional time division multiplexing voice services; and synchronous optical network-based ethernet, legacy data hosting services, and conferencing services. The company was formerly known as CenturyLink, Inc. and changed its name to Lumen Technologies, Inc. in September 2020. The company was incorporated in 1968 and is headquartered in Monroe, Louisiana.
NYSE ended the session with Lumen Technologies sliding 28.42% to $1.05 on Wednesday while NYSE rose 0.56% to $15,002.55.
Earnings Per Share
As for profitability, Lumen Technologies has a trailing twelve months EPS of $-10.84.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -147.78%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Lumen Technologies’s stock is considered to be oversold (<=20).
Previous days news about Lumen Technologies
- : lumen technologies’ stock rises on revenue beat. According to MarketWatch on Tuesday, 31 October, "Shares of Lumen Technologies have plunged 72% this year, while the broader S&P 500 index has increased 9%."
More news about Lumen Technologies.
2. Estee Lauder Companies (EL) – -17.37%
The Estée Lauder Companies Inc. manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. It offers skin care products, including moisturizers, serums, cleansers, toners, body care, exfoliators, acne care and oil correctors, facial masks, and sun care products; and makeup products, such as lipsticks, lip glosses, mascaras, foundations, eyeshadows, nail polishes, and powders, as well as compacts, brushes, and other makeup tools. The company also provides fragrance products in various forms comprising eau de parfum sprays and colognes, as well as lotions, powders, creams, candles, and soaps; and hair care products that include shampoos, conditioners, styling products, treatment, finishing sprays, and hair color products, as well as sells ancillary products and services. It offers its products under the Estée Lauder, Clinique, Origins, M·A·C, Bobbi Brown Cosmetics, La Mer, Aveda, Jo Malone London, TOM FORD, Too Faced, Dr.Jart+, and The Ordinary brands. The company sells its products through department stores, specialty-multi retailers, upscale perfumeries and pharmacies, and salons and spas; freestanding stores; its own and authorized retailer websites; third-party online malls; stores in airports; and duty-free locations. The Estée Lauder Companies Inc. was founded in 1946 and is headquartered in New York, New York.
NYSE ended the session with Estee Lauder Companies dropping 17.37% to $106.48 on Wednesday, after two sequential sessions in a row of gains. NYSE jumped 0.56% to $15,002.55, after two consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Estee Lauder Companies has a trailing twelve months EPS of $2.78.
PE Ratio
Estee Lauder Companies has a trailing twelve months price to earnings ratio of 38.3. Meaning, the purchaser of the share is investing $38.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.72%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Estee Lauder Companies’s EBITDA is 300.24.
Yearly Top and Bottom Value
Estee Lauder Companies’s stock is valued at $106.48 at 17:32 EST, way under its 52-week low of $123.64.
Moving Average
Estee Lauder Companies’s worth is way under its 50-day moving average of $147.03 and way below its 200-day moving average of $201.80.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.3%, now sitting on 15.91B for the twelve trailing months.
More news about Estee Lauder Companies.
3. Match Group (MTCH) – -16.27%
Match Group, Inc. provides dating products worldwide. The company's portfolio of brands includes Tinder, Match, The League, Azar, Meetic, OkCupid, Hinge, Pairs, PlentyOfFish, and Hakuna, as well as a various other brands. The company was incorporated in 1986 and is based in Dallas, Texas.
NASDAQ ended the session with Match Group sliding 16.27% to $28.97 on Wednesday while NASDAQ rose 1.64% to $13,061.47.
Earnings Per Share
As for profitability, Match Group has a trailing twelve months EPS of $1.64.
PE Ratio
Match Group has a trailing twelve months price to earnings ratio of 17.66. Meaning, the purchaser of the share is investing $17.66 for every dollar of annual earnings.
Yearly Top and Bottom Value
Match Group’s stock is valued at $28.97 at 17:32 EST, below its 52-week low of $30.73.
Moving Average
Match Group’s value is way under its 50-day moving average of $40.69 and way under its 200-day moving average of $40.96.
Previous days news about Match Group
- Match group (mtch) reports Q3 earnings: what key metrics have to say. According to Zacks on Tuesday, 31 October, "For the quarter ended September 2023, Match Group (MTCH Quick QuoteMTCH – Free Report) reported revenue of $881.6 million, up 8.9% over the same period last year. ", "Here is how Match Group performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
More news about Match Group.
4. Trimble (TRMB) – -15.26%
Trimble Inc. provides technology solutions that enable professionals and field mobile workers to enhance or transform their work processes worldwide. The company's Buildings and Infrastructure segment offers field and office software for route selection and design; systems to guide and control construction equipment; software for 3D design and data sharing; systems to monitor, track, and manage assets, equipment, and workers; software to share and communicate data; program management solutions for construction owners; 3D conceptual design and modeling software; building information modeling software; enterprise resource planning, project management, and project collaboration solutions; integrated site layout and measurement systems; cost estimating, scheduling, and project controls solutions; and applications for sub-contractors and trades. Its Geospatial segment provides surveying and geospatial products, and geographic information systems. The company's Resources and Utilities segment offers precision agriculture products and services, such as guidance and positioning systems, including autonomous steering systems, automated and variable-rate application and technology systems, and information management solutions; manual and automated navigation guidance for tractors and other farm equipment; solutions to automate application of pesticide and seeding; water solutions; and agricultural software. Its Transportation segment offers solutions for long haul trucking and freight shipper markets; mobility solutions comprising route management, safety and compliance, end-to-end vehicle management, video intelligence, and supply chain communications; and fleet and transportation management systems, analytics, routing, mapping, reporting, and predictive modeling solutions. The company was formerly known as Trimble Navigation Limited and changed its name to Trimble Inc. in October 2016. Trimble Inc. was founded in 1978 and is headquartered in Westminster, Colorado.
NASDAQ ended the session with Trimble dropping 15.26% to $39.94 on Wednesday while NASDAQ jumped 1.64% to $13,061.47.
Trimble (trmb) reports Q3 earnings: what key metrics have to sayHere is how Trimble performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Earnings Per Share
As for profitability, Trimble has a trailing twelve months EPS of $1.39.
PE Ratio
Trimble has a trailing twelve months price to earnings ratio of 28.73. Meaning, the purchaser of the share is investing $28.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.38%.
More news about Trimble.
5. Unum Group (UNM) – -12.08%
Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block and Corporate segments. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products. It also provides group pension, individual life and corporate-owned life insurance, reinsurance pools and management operations, and other miscellaneous products. The company sells its products primarily to employers for the benefit of employees. Unum Group sells its products through field sales personnel, independent brokers, consultants, and independent contractor agency sales force. Unum Group was founded in 1848 and is based in Chattanooga, Tennessee.
NYSE ended the session with Unum Group sliding 12.08% to $42.99 on Wednesday, after two sequential sessions in a row of gains. NYSE jumped 0.56% to $15,002.55, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Unum Group has a trailing twelve months EPS of $7.29.
PE Ratio
Unum Group has a trailing twelve months price to earnings ratio of 5.9. Meaning, the purchaser of the share is investing $5.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.38%.
Volume
Today’s last reported volume for Unum Group is 3766060 which is 285.75% above its average volume of 976289.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Oct 25, 2023, the estimated forward annual dividend rate is 1.46 and the estimated forward annual dividend yield is 3.04%.
More news about Unum Group.
6. Ebix (EBIX) – -11.33%
Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia.
NASDAQ ended the session with Ebix dropping 11.33% to $5.40 on Wednesday while NASDAQ jumped 1.64% to $13,061.47.
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of ebix, inc. – EBIXThe investigation concerns whether Ebix and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Earnings Per Share
As for profitability, Ebix has a trailing twelve months EPS of $1.09.
PE Ratio
Ebix has a trailing twelve months price to earnings ratio of 4.95. Meaning, the purchaser of the share is investing $4.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.64%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 52.8%, now sitting on 874.3M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Ebix’s EBITDA is 42.8.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 88.1% and a negative 38.5%, respectively.
More news about Ebix.
7. V.F. Corporation (VFC) – -10.22%
V.F. Corporation, together with its subsidiaries, engages in the design, procurement, marketing, and distribution of branded lifestyle apparel, footwear, and related products for men, women, and children in the Americas, Europe, and the Asia-Pacific. It operates through three segments: Outdoor, Active, and Work. The company offers outdoor, merino wool and other natural fibers-based, lifestyle, and casual apparel; footwear; equipment; accessories; outdoor-inspired, performance-based, youth culture/action sports-inspired, streetwear, and protective work footwear; handbags, luggage, backpacks, and totes; and work and work-inspired lifestyle apparel and footwear. It provides its products under The North Face, Timberland, Smartwool, Icebreaker, Altra, Vans, Supreme, Kipling, Napapijri, Eastpak, JanSport, Dickies, and Timberland PRO brand names. The company sells its products primarily to specialty stores, department stores, national chains, and mass merchants, as well as sells through direct-to-consumer operations, including retail stores, concession retail stores, and e-commerce sites, and other digital platforms. V.F. Corporation was founded in 1899 and is headquartered in Denver, Colorado.
NYSE ended the session with V.F. Corporation falling 10.22% to $13.23 on Wednesday, after two successive sessions in a row of losses. NYSE jumped 0.56% to $15,002.55, after two consecutive sessions in a row of gains, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, V.F. Corporation has a trailing twelve months EPS of $-0.55.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.86%.
More news about V.F. Corporation.
8. Canaan (CAN) – -7.55%
Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.
NASDAQ ended the session with Canaan falling 7.55% to $1.78 on Wednesday, following the last session’s downward trend. NASDAQ jumped 1.64% to $13,061.47, after three consecutive sessions in a row of gains, on what was an all-around positive trend exchanging session today.
Earnings Per Share
As for profitability, Canaan has a trailing twelve months EPS of $-0.47.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.89%.
Yearly Top and Bottom Value
Canaan’s stock is valued at $1.78 at 17:32 EST, way under its 52-week high of $3.98 and above its 52-week low of $1.64.
More news about Canaan.
9. Bionano Genomics (BNGO) – -6.88%
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.
NASDAQ ended the session with Bionano Genomics sliding 6.88% to $1.29 on Wednesday, after two sequential sessions in a row of gains. NASDAQ jumped 1.64% to $13,061.47, after three successive sessions in a row of gains, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, Bionano Genomics has a trailing twelve months EPS of $-7.4.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.67%.
Volume
Today’s last reported volume for Bionano Genomics is 581930 which is 35.86% below its average volume of 907315.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 11.8% and 28.5%, respectively.
More news about Bionano Genomics.
10. E.I. du Pont de Nemours and Company (DD) – -6.76%
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through Electronics & Industrial, Water & Protection, and Corporate & Other segments. The Electronics & Industrial segment supplies materials and solutions for the fabrication of semiconductors and integrated circuits addressing various steps of the manufacturing process. This segment also provides semiconductor and advanced packaging materials; dielectric and metallization solutions for chip packaging; and silicones for light emitting diode packaging and semiconductor applications; permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, and electroless and electrolytic metallization solutions, as well as patterning solutions, and materials and metallization processes for metal finishing, decorative, and industrial applications. In addition, it offers various materials to manufacture rigid and flexible displays for organic light emitting diode, and other display applications, as well as provides high performance parts, and specialty silicone elastomers, and lubricants to automotive, aerospace, electronics, industrial, and healthcare markets. The Water & Protection segment provides engineered products and integrated systems for worker safety, water purification and separation, transportation, energy, medical packaging and building materials. The Corporate & Other segment offers auto adhesives and fluids; Multibase; and Tedlar products. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.
NYSE ended the session with E.I. du Pont de Nemours and Company dropping 6.76% to $67.95 on Wednesday while NYSE jumped 0.56% to $15,002.55.
Earnings Per Share
As for profitability, E.I. du Pont de Nemours and Company has a trailing twelve months EPS of $2.03.
PE Ratio
E.I. du Pont de Nemours and Company has a trailing twelve months price to earnings ratio of 33.47. Meaning, the purchaser of the share is investing $33.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.82%.
Sales Growth
E.I. du Pont de Nemours and Company’s sales growth for the next quarter is negative 20.6%.
More news about E.I. du Pont de Nemours and Company.
Stay up to date with our winners and losers daily report
